Clinical Trial Update: Botulinum Toxin Type A for Neuroma Pain [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating botulinum toxin type A for neuroma pain has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroma

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Southern Illinois University | Conditions: Neuroma | Phase 2 | Status: WITHDRAWN